FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Deborah Panebianco

Research Profile

Concepts & Ideas

Chemicals & Drugs

Procedures

Phenomena

Physiology

Drug Interactions

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
S Aubrey Stoch; Julie A Stone; Lucas van Bortel; Stefan Zajic; Caroline Cilissen; Yu Ding; Keith M Gottesdiener; Kenneth C Lasseter; Lida Liu; Qi Liu; Deborah L Miller; Deborah Panebianco; Barnali Pramanik; Boyd B Scott; John A Wagner
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers.
Mark Stroh; Michele Trucksis; John A Wagner; Nancy Agrawal; Amy Johnson-Levonas; Axel Juan; Xiaodong Li; Sabrina Marsilio; Gail Murphy; Keith Orford; Deborah Panebianco; Marian Iwamoto
The minimal impact of food on the pharmacokinetics of ridaforolimus.
Mark Stroh; Michele Trucksis; John A Wagner; Nancy Agrawal; Sheila Breidinger; Amy Johnson-Levonas; Walter K Kraft; Sabrina Marsilio; Jacqueline McCrea; Gail Murphy; Keith Orford; John Palcza; Deborah Panebianco; Marian Iwamoto
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Deborah Panebianco (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S Aubrey Stoch; Julie A Stone; Lucas van Bortel; Stefan Zajic; Caroline Cilissen; Yu Ding; Keith M Gottesdiener; Kenneth C Lasseter; Lida Liu; Qi Liu; Deborah L Miller; Deborah Panebianco; Barnali Pramanik; Boyd B Scott; John A Wagner
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers.
British journal of clinical pharmacology 2013;75(5):1240-54.
2012: Mark Stroh; Michele Trucksis; John A Wagner; Nancy Agrawal; Amy Johnson-Levonas; Axel Juan; Xiaodong Li; Sabrina Marsilio; Gail Murphy; Keith Orford; Deborah Panebianco; Marian Iwamoto
The minimal impact of food on the pharmacokinetics of ridaforolimus.
Cancer chemotherapy and pharmacology 2012;70(1):177-82.
2012: Mark Stroh; Michele Trucksis; John A Wagner; Nancy Agrawal; Sheila Breidinger; Amy Johnson-Levonas; Walter K Kraft; Sabrina Marsilio; Jacqueline McCrea; Gail Murphy; Keith Orford; John Palcza; Deborah Panebianco; Marian Iwamoto
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
Cancer chemotherapy and pharmacology 2012;69(5):1247-53.
2012: B R Chaitman; Jeffrey A Chodakewitz; S G Chrysant; A L Free; I Heirman; A P Ho; T W Ho; Z Kobalava; T Laethem; S Y Martsevich; M Gail Murphy; J S Palcza; Deborah Panebianco; J F Rowe; M O Behm; N Bittar; R L Blanchard
A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.
Clinical pharmacology and therapeutics 2012;91(3):459-66.
2011: Thomas C Marbury; Luzelena Caro; Bo Jin; Phung L Ngo; Deborah Panebianco; CR Shadle; Jack Valentine; Gail Murphy
Pharmacokinetics of oral dexamethasone and midazolam when administered with single-dose intravenous 150 mg fosaprepitant in healthy adult subjects.
Journal of clinical pharmacology 2011;51(12):1712-20.
2011: S Aubrey Stoch; Cynthia Gargano; Jack Valentine; Matthew P Braun; M Gail Murphy; Margaret Fedgchin; Anup Majumdar; Edward Pequignot; Keith M Gottesdiener; Petty Kevin; Deborah Panebianco; Dennis Dean; walter kraft; Howard E Greenberg
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.
Cancer chemotherapy and pharmacology 2011;67(6):1313-21.
2009: S Aubrey Stoch; S Zajic; J Stone; D L Miller; Kristien van Dyck; M J Gutierrez; M De Decker; Lida Liu; Q Liu; B B Scott; Deborah Panebianco; B Jin; L T Duong; Keith M Gottesdiener; John A Wagner
Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies.
Clinical pharmacology and therapeutics 2009;86(2):175-82.
2007: Ronald J Hogg; Angela Delucchi; Graciela Sakihara; Thomas G Wells; Frank Tenney; Donald L Batisky; Jeffrey L Blumer; Beth A Vogt; Man-Wai Lo; Elizabeth Hand; Deborah Panebianco; Ronda Rippley; Wayne Shaw; Shahnaz Shahinfar
A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension.
Pediatric nephrology (Berlin, Germany) 2007;22(5):695-701.
2006: Susie Xiujiang Li; Edward Pequignot; Deborah Panebianco; Paul Lupinacci; Anup Majumdar; Laura Rosen; Tuli Ahmed; Jane E Royalty; Thomas H Rushmore; M Gail Murphy; Petty Kevin
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
Journal of clinical pharmacology 2006;46(7):792-801.
2006: Anup K Majumdar; Laura Howard; Michael R Goldberg; Lisa Hickey; Marvin Constanzer; Paul L Rothenberg; Tami M Crumley; Deborah Panebianco; Thomas E Bradstreet; Arthur J Bergman; Scott A Waldman; Howard E Greenberg; Kathleen Butler; A Knops; Inge De Lepeleire; Nicole Michiels; Petty Kevin
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.
Journal of clinical pharmacology 2006;46(3):291-300.
2005: M Depré; Anne Van Hecken; M Oeyen; Inge De Lepeleire; Tine Laethem; Paul L Rothenberg; Petty Kevin; Anup Majumdar; Tami M Crumley; Deborah Panebianco; A Bergman; Jan de Hoon
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
European journal of clinical pharmacology 2005;61(5-6):341-6.
2005: Peter Nygren; Kenneth Hande; Petty Kevin; Margaret Fedgchin; Kristien van Dyck; Anup Majumdar; Deborah Panebianco; Marina De Smet; Tuli Ahmed; M Gail Murphy; Keith M Gottesdiener; Veronique Cocquyt; Simon Van Belle
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.
Cancer chemotherapy and pharmacology 2005;55(6):609-16.
2005: Larissa A Wenning; M Gail Murphy; Laura P James; Jeffrey L Blumer; James D Marshall; R John Baier; ANN SCHEIMANN; Deborah Panebianco; Ling Zhong; Roy Eisenhandler; Kuang C Yeh; Gregory L Kearns
Pharmacokinetics of famotidine in infants.
Clinical pharmacokinetics 2005;44(4):395-406.
2003: Anup K Majumdar; Jacqueline B McCrea; Deborah Panebianco; Michael Hesney; James Dru; Marvin Constanzer; Michael R Goldberg; Gail Murphy; Keith M Gottesdiener; Christopher R Lines; Petty Kevin; Robert A Blum
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe.
Clinical pharmacology and therapeutics 2003;74(2):150-6.
2003: Jacqueline B McCrea; Anup K Majumdar; Michael R Goldberg; Marian Iwamoto; Cynthia Gargano; Deborah Panebianco; Michael Hesney; Christopher R Lines; Petty Kevin; Paul J Deutsch; M Gail Murphy; Keith M Gottesdiener; D Ronald Goldwater; Robert A Blum
Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone.
Clinical pharmacology and therapeutics 2003;74(1):17-24.
2003: Robert A Blum; Anup Majumdar; Jacqueline B McCrea; John Busillo; Laura H Orlowski; Deborah Panebianco; Michael Hesney; Petty Kevin; Michael R Goldberg; M Gail Murphy; Keith M Gottesdiener; Carolyn M Hustad; Christian Lates; walter kraft; Sandi Van Buren; Scott A Waldman; Howard E Greenberg
Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects.
Clinical therapeutics 2003;25(5):1407-19.
2001: Donald G Musson; Kimberly L Birk; Deborah Panebianco; KD Gagliano; John D Rogers; Michael R Goldberg
Pharmacokinetics of rizatriptan in healthy elderly subjects.
International journal of clinical pharmacology and therapeutics 2001;39(10):447-52.
2001: T Wells; Ronda K Rippley; R Hogg; Abdullah Sakarcan; D Blowey; Philip Walson; B Vogt; A Delucchi; Man-Wai Lo; Elizabeth Hand; Deborah Panebianco; Wayne Shaw; Shahnaz Shahinfar
The pharmacokinetics of enalapril in children and infants with hypertension.
Journal of clinical pharmacology 2001;41(10):1064-74.
2000: Howard E Greenberg; P Wissel; J Barrett; A Barchowsky; R Gould; D Farrell; Deborah Panebianco; Elizabeth Hand; Lisa P Gillen; Michael R Goldberg; TD Bjornsson
Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers.
Journal of clinical pharmacology 2000;40(5):496-507.
2000: Michael R Goldberg; Yih Lee; Kamlesh P Vyas; Donald E Slaughter; Deborah Panebianco; S J Ermlich; CR Shadle; MJ Brucker; Debra McLoughlin; Timothy V Olah
Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects.
Journal of clinical pharmacology 2000;40(1):74-83.